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Background: Current guidelines for the use of implantable cardioverter-defibrillators (ICDs) are broad and
significantly increase the cost of caring for patientswith heart failure. In an effort to identify the specific subset
of patients who benefit from this therapy, the predictive value of numerous echocardiographic parameters
have been studied. Severe diastolic dysfunction has been shown to predict adverse events in a group of
patientswho received an ICD for secondary prevention, but has not been tested in those who receive ICDs for
primary prevention.
Hypothesis: We tested the hypothesis that a restrictivemitral inflow pattern on echocardiographywill predict
the risk of appropriate therapy in this patient population.
Methods: This retrospective study identified 145 consecutive patients who met primary prevention criteria
for ICD implantation and had an echo performed no more than 1 year prior to receiving the ICD. A restrictive
patternwas defined as a mitral inflow E/A>2 or a deceleration time <150 ms.
Results:A restrictive patternwas present in 69patients (40.7%of the group). Appropriate ICD therapyoccurred
in 8 (11.5%) subjects with a restrictive pattern and 14 (18.4%) with a nonrestrictive pattern over 680 days of
average follow-up (P = not significant). Cox regression analysis showed the presence of a restrictive pattern
was not helpful in predicting time to first ICD therapy.
Conclusions: In a populationof patientswho received ICDs for primary prevention,echocardiographic findings
of severe diastolic dysfunctionwere not helpful in targeting the use of ICDs to those at highest risk.
Introduction
Arrhythmias account for up to 51% of deaths in those with
a low ejection fraction (EF) untreated with implantable
cardioverter-defibrillators (ICDs).1 The Multicenter Auto-
matic Defibrillator Implantation Trial (MADIT-11)2 and
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)3
trials demonstrated that ICDs can significantly reduce
mortality from sudden cardiac death when implanted pro-
phylactically in patients with an EF less than 30% to 35%.
This broad selection criterion has led to a dramatic increase
in ICD implantations over the last 5 years. The expense
of these devices considerably increases the cost of heart
failure care.4 There is growing interest in determining how
to identify the subset of patients who will benefit from ICD
implantation. While some models of prognosis based on
clinical and echocardiographic criteria are able to predict
overall mortality in patients with systolic heart failure, these
have proven to be more predictive of pump failure; most fail
in predicting sudden death specifically.5
A high E/E′ as measured by tissue Doppler and a restric-
tive pattern detected by pulse wave Doppler of the mitral
inflow both correlate with overall mortality in patients with
a low ejection fraction.6 – 8 It is not clear if these parame-
ters indicate an increased risk of death from pump failure,
arrhythmia, or both. One study suggests that in a subgroup
of patients, a restrictive mitral inflow pattern and, to a lesser
extent, a high E/E′ on tissue Doppler are independent risk
factors for ICD discharges.9 This study was small, and it was
composed mainly of a subgroup of patients at very high risk
(74% had ICD implantation for secondary prevention and
30% were on oral antiarrhythmic agents). It remains unclear
if there is an association between arrhythmic events and
diastolic parameters among patients who receive ICDs for
primary prevention. This question is the focus of our study.
Methods
Patient Selection
After approval from the institutional review board, we
conducted a retrospective study of all patients over age
18 at the University of Michigan who had an EF <35%
and received an ICD for primary prevention of sudden
cardiac death between March 21, 2002 (the date of publi-
cation of MADIT-II) and July 1, 2005. Also, subjects had
to have at least 2 months of electrophysiology follow-up
(the time of first ICD interrogation) within the University
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of Michigan system. Patients with a history of ventric-
ular arrhythmias, syncope, hypertrophic cardiomyopathy,
or congenital heart disease were excluded. Of these 267
subjects, we identified 145 consecutive patients who also
received an echocardiogram during which diastolic param-
eters were measured no more than 1 year prior to the ICD
implantation.
Echocardiography
Various measurements from the echocardiograms were
obtained. Left ventricular end-diastolic and end-systolic
diameters were measured in the parasternal long axis view.
Left atrial volume was measured at end-systole in the apical
4-chamber view. The peak E wave and A wave velocities
as well as E wave deceleration times were measured from
the pulse wave Doppler spectra of mitral valve inflow. All
recorded beats were measured, and a mean was calculated
to obtain the E to A ratio and deceleration times. The EF
was calculated using Simpson’s method to determine left
ventricular end-diastolic and end-systolic volumes. When a
good quality 2-chamber view was available, a biplane method
was used. If the endocardial borders in this view were not
visualized or if it was foreshortened,EF was calculated from
the apical 4-chamber view alone. Mitral regurgitation was
graded semiquantitatively. The maximum regurgitant jet
area was also measured.
Statistical Analysis
In patientswith sinus rhythm,a restrictivefilling patternwas
definedas an E to A ratio>2 or a decelerationtime<150 ms.
Because of atrial fibrillation or paced rhythms, 36 of the 145
subjects did not have discernable A waves on mitral inflow
patterns. In these cases only the deceleration time was used
to define a restrictive pattern. The primary endpoint was
an appropriate ICD discharge therapy which was defined
as the initiation of either a shock or antitachycardia pacing
for confirmed ventricular tachycardia (VT) or ventricular
fibrillation. Cox regression analysis was used to identify
independent predictors of the first ICD discharge or death
as primary endpoint. All statistical analysis was completed
using SPSS version 14 (Chicago, IL). A P value of <.05 was
used to define statistical significance. Continuous variables
are expressed as mean ± SD.
Results
The follow-up period was 680±419 days. During this time,
22 (15.2%) subjects had a primary event. First therapies
consisted of ICD discharge in 15 subjects and antitachycar-
dia pacing in 7. An event occurred in 8 (11.5%) of those
with a restrictive pattern vs 14 (18.4%) without a restrictive
pattern (P = not significant). The baseline characteristics
of the studied patient sample are shown in Table 1. Those
with a restrictive pattern were more likely to be receiving
a loop diuretic and to have a slightly lower serum sodium.
Table 1. Baseline Characteristics of the Group of Those With a Restrictive




n = 76 P Value
Age 59 ± 11y 61± 12 y .301
Male gender 81% 79% .836
Medication use
Aspirin 74% 68% .583
β-Blockers 91% 86% .193
ACE inhibitors 88% 87% .806
Loop Diuretics 88% 67% .003
Spironolactone 42% 45% .867
Digoxin 49% 61% .246
Antiarrhythimcs 12% 12% 1.000
Class
1 or 2 30% 46% .363
3 or 4 70% 54% .363
Ischemic 75% 65% .145
Valve disease 13% 13% 1.000
Prior bypass surgery 39% 46% .407
Prior infarction 51% 51% 1.000
Prior PTCA 26% 22% .698
Diabetes 39% 37% .864
Hyperlipidemia 80% 78% .840
COPD 7% 9% .768
QRS duration 136±33 ms 137±33 ms .909
Sodium 139±4 mg/dl 140±3 mg/dl .042
Creatinine clearance 83±27 ml/min 98±63 ml/min .088
Hematocrit 39±5 38±5 .223
Continuous variables are expressed as mean ± Standard Deviation.
The results of the univariable regression analysis are shown
in Table 2. None of the clinical or echocardiographic vari-
ables we investigatedwere significantin predictingan event.
There was no difference in the rate of events between those
who had a restrictive pattern vs those who did not. No other
echocardiographic measurements including left ventricular
size, left atrial volume, EF, or presence of significant mitral
regurgitation predicted events.
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Clinical Investigations continued
Table 2. Predictive Value of Echocardiographic and Clinical Variables on
Event-free Survival by Univariable Analysis
Variable P Value
Restrictive pattern .143
Mitral regurgitation area .781
Left atrial volume .259
Ejection Fraction .425
Left ventricular end-systolic volume .861


















Multiple studies have clearly shown that severe diastolic
dysfunction is associated with increased mortality among
patients with a low EF.6 – 8 It is unclear if severe dias-
tolic dysfunction is associated with an increase in mor-
tality from pump failure, arrhythmic death, or both. The
study by Bruch et al9 suggested that a restrictive mitral
inflow pattern predicts ICD therapy and death in patients
with systolic heart failure. The patient group they stud-
ied, however, was largely comprised of patients requiring
ICDs for secondary prevention, and many of them were
already on oral antiarrhythmic therapy. In contrast, the
current study was comprised entirely of patients who
received ICDs for primary prevention, and we found no
association between a baseline restrictive mitral inflow
pattern and subsequent appropriate ICD tachyarrhyth-
mia therapy, suggesting that severe diastolic dysfunc-
tion in these patients is not associated with arrhythmic
events.
If severe diastolic dysfunction predicts overall mortality
in a general sample of heart failure patients and also
predicts arrhythmic events in a secondary prevention
sample, why did it fail to predict arrhythmias in our primary
prevention sample? One possibility is that among our group
of primary preventionpatients, a larger proportionof treated
arrhythmias may have been nonlife-threatening, compared
to the arrhythmias treated in secondary prevention patients
in the study by Bruch et al.9 ICDs also treat episodes of
VT, particularly slow VT, that would otherwise abort on
their own before causing death or syncope.10 As such, it is
possible that the degree of overtreatmentwas greater in our
sample than in that studied by Bruch et al.9 A larger, longer
study that examines the relationship between the degree of
diastolic dysfunction and actual arrhythmic mortality may
provide further information.
A second possible explanation for the negative results of
our study is that it examined a lower risk populationand was
not adequately powered to detect a difference at these low
rates. Of note, however, our study’s larger sample size and
longer follow-up duration resulted in a similar event risk to
the study conducted by Bruch et al.9 As such, the sample
size does not explain the differences observed between the
2 studies.
In the current study, no other echocardiographic mea-
surement was helpful in predicting ICD events. This result
is consistent with previous studies in which left ventricular
size and EF have failed to consistently predict mortality or
arrhythmicevents.7,11 Although mitral regurgitationand left
atrial volume have been previously associated with overall
mortality,12 we are unaware of any studies that have focused
on a specific relationship with ventricular arrhythmias.
A limitation of our study was the inclusion of patients who
had ICDs implanted with and without cardiac resynchro-
nization (CRT, or biventricular pacing). Of the 145 patients
in our study, 58 (38%) had CRT capability. Biventricular
pacing can lead to reverse remodeling that may alter sev-
eral echocardiographicparametersincludingleft ventricular
size, left atrial size, the degree of mitral regurgitation, and
the mitral inflow pattern. Left ventricular reverse remodel-
ing may explain why biventricular pacing decreases death
and arrhythmias in patients with cardiomyopathy.13 In the
Cox regression analysis, however, biventricular pacing was
not predictive of events. Eliminating these patients from the
analysis also failed to identify any association between echo
parameters and events.
The search for an accurate model to predict sudden
death in patients with systolic heart failure remains
elusive. While electrocardiographic measurements like QRS
duration and T-wave alternans may enhance sudden death
risk stratification, additional tools are needed.14 – 16 This
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study suggests that current echocardiographic parameters
may not be helpful in further risk stratifying such patients.
Specifically, in a population with no known history of
arrhythmic events, a restrictive mitral inflow pattern was
not helpful in identifying those patients who received
appropriate ICD antitachycardia therapy.
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